WEX Pharmaceuticals Inc. is a biopharmaceutical company based in Vancouver, Canada and is developing a late-stage non-opioid analgesic, Halneuron®.
Halneuron is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology:
- No evidence of addiction, withdrawal symptoms and euphoria
- No evidence of tolerance build up over time
- Evidence of long duration of pain relief with minimal side effects
- Acceptable safety profile for human use and tested in over 500 patients to date
Halneuron is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.